Cargando…

Asiatic Acid Exhibits Anti-inflammatory and Antioxidant Activities against Lipopolysaccharide and d-Galactosamine-Induced Fulminant Hepatic Failure

Inflammation and oxidative stress are essential for the pathogenesis of fulminant hepatic failure (FHF). Asiatic acid (AA), which is a pentacyclic triterpene that widely occurs in various vegetables and fruits, has been reported to possess antioxidant and anti-inflammatory properties. In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lv, Hongming, Qi, Zhimin, Wang, Sisi, Feng, Haihua, Deng, Xuming, Ci, Xinxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500632/ https://www.ncbi.nlm.nih.gov/pubmed/28736552 http://dx.doi.org/10.3389/fimmu.2017.00785

Ejemplares similares

Nrf2 signaling and autophagy are complementary in protecting lipopolysaccharide/d-galactosamine-induced acute liver injury by licochalcone A
por: Lv, Hongming, et al.
Publicado: (2019)

A novel scoring system for prognostic prediction in d-galactosamine/lipopolysaccharide-induced fulminant hepatic failure BALB/c mice
por: Feng, Bo, et al.
Publicado: (2009)

Xanthohumol ameliorates lipopolysaccharide (LPS)-induced acute lung injury via induction of AMPK/GSK3β-Nrf2 signal axis
por: Lv, Hongming, et al.
Publicado: (2017)

Crocetin protects against fulminant hepatic failure induced by lipopolysaccharide/D-galactosamine by decreasing apoptosis, inflammation and oxidative stress in a rat model
por: Gao, Ke, et al.
Publicado: (2019)

Protective Effect of Luteolin on D-Galactosamine (D-Gal)/Lipopolysaccharide (LPS) Induced Hepatic Injury by in Mice
por: Pu, Yiwei, et al.
Publicado: (2021)

Protective Effect of Danhong Injection on Acute Hepatic Failure Induced by Lipopolysaccharide and D-Galactosamine in Mice
por: Wang, Ying, et al.
Publicado: (2014)

Isoorientin Ameliorates APAP-Induced Hepatotoxicity via Activation Nrf2 Antioxidative Pathway: The Involvement of AMPK/Akt/GSK3β
por: Fan, Xiaoye, et al.
Publicado: (2018)

Sinapic acid ameliorates D-galactosamine/lipopolysaccharide-induced fulminant hepatitis in rats: Role of nuclear factor erythroid-related factor 2/heme oxygenase-1 pathways
por: Ansari, Mushtaq Ahmad, et al.
Publicado: (2021)

Deficiency of interleukin-19 exacerbates lipopolysaccharide/D-galactosamine-induced acute liver failure
por: FUJIMOTO, Yasuyuki, et al.
Publicado: (2020)

Carfilzomib Mitigates Lipopolysaccharide/D-Galactosamine/Dimethylsulfoxide-Induced Acute Liver Failure in Mice
por: Alhareth, Dhafer Y., et al.
Publicado: (2023)

Metabonomic analysis of liver tissue from BALB/c mice with d-galactosamine/lipopolysaccharide-induced acute hepatic failure
por: Feng, Bo, et al.
Publicado: (2013)

BRP, a polysaccharide fraction isolated from Boschniakia rossica, protects against galactosamine and lipopolysaccharide induced hepatic failure in mice
por: Quan, Jishu, et al.
Publicado: (2014)

Intraperitoneal Administration of Fetuin-A Attenuates d-Galactosamine/Lipopolysaccharide-Induced Liver Failure in Mouse
por: Zhang, Pan, et al.
Publicado: (2014)

Licochalcone A Upregulates Nrf2 Antioxidant Pathway and Thereby Alleviates Acetaminophen-Induced Hepatotoxicity
por: Lv, Hongming, et al.
Publicado: (2018)

Lysimachiae Herba Inhibits Inflammatory Reactions and Improves Lipopolysaccharide/D-Galactosamine-Induced Hepatic Injury
por: Jeong, Yun Hee, et al.
Publicado: (2021)

Chicoric acid ameliorate inflammation and oxidative stress in Lipopolysaccharide and d‐galactosamine induced acute liver injury
por: Li, Zheng, et al.
Publicado: (2020)

Gasdermin D Inhibitor Necrosulfonamide Alleviates Lipopolysaccharide/D-galactosamine-induced Acute Liver Failure in Mice
por: Wu, Yi-Long, et al.
Publicado: (2022)

Guanabenz Prevents d-Galactosamine/Lipopolysaccharide-Induced Liver Damage and Mortality
por: Perego, Jessica, et al.
Publicado: (2017)

Co-administration of lipopolysaccharide and d-galactosamine induces genotoxicity in mouse liver
por: Dong, Wenjing, et al.
Publicado: (2021)

Levosimendan Increases Survival in a D-Galactosamine and Lipopolysaccharide Rat Model
por: Sakaguchi, Tatsuma, et al.
Publicado: (2022)

Mitochondria-Dependent Apoptosis of Con A-Activated T Lymphocytes Induced by Asiatic Acid for Preventing Murine Fulminant Hepatitis
por: Guo, Wenjie, et al.
Publicado: (2012)

Nature and mechanisms of hepatocyte apoptosis induced by d-galactosamine/lipopolysaccharide challenge in mice
por: WU, YI-HANG, et al.
Publicado: (2014)

The Protective Effect of Cordycepin on D-Galactosamine/Lipopolysaccharide-Induced Acute Liver Injury
por: Li, Jin, et al.
Publicado: (2017)

Protective Role of Mytilus edulis Hydrolysate in Lipopolysaccharide-Galactosamine Acute Liver Injury
por: Starikova, Eleonora, et al.
Publicado: (2021)

NOD1 Agonist Protects Against Lipopolysaccharide and D-Galactosamine-Induced Fatal Hepatitis Through the Upregulation of A20 Expression in Hepatocytes
por: Jia, Fang, et al.
Publicado: (2021)

Esculetin Alleviates Acute Liver Failure following Lipopolysaccharide/D-Galactosamine in Male C57BL/6 Mice
por: Mohamadi-Zarch, Seyed-Mahdi, et al.
Publicado: (2021)

Shikonin protects against D-Galactosamine and lipopolysaccharide-induced acute hepatic injury by inhibiting TLR4 signaling pathway
por: Lin, Meng-Xiang, et al.
Publicado: (2017)

Hepatic TGFβr1 Deficiency Attenuates Lipopolysaccharide/D-Galactosamine–Induced Acute Liver Failure Through Inhibiting GSK3β–Nrf2–Mediated Hepatocyte Apoptosis and Ferroptosis
por: Huang, Sha, et al.
Publicado: (2022)

Neurological Management of Fulminant Hepatic Failure
por: Frontera, Jennifer A., et al.
Publicado: (2010)

Fulminant hepatic failure: An unusual suspect
por: Layios, Nathalie, et al.
Publicado: (2023)

Hepatoprotective Effects of Kaempferol-3-O-α-l-Arabinopyranosyl-7-O-α-l-Rhamnopyranoside on d-Galactosamine and Lipopolysaccharide Caused Hepatic Failure in Mice
por: Dong, Lin, et al.
Publicado: (2017)

Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice
Publicado: (1987)

The Protection of Midazolam Against Immune Mediated Liver Injury Induced by Lipopolysaccharide and Galactosamine in Mice
por: Li, Jian, et al.
Publicado: (2019)

Fulminant Hepatic Failure Secondary to Primary Hepatic Angiosarcoma
por: Abegunde, Ayokunle T., et al.
Publicado: (2015)

The Protective Role of Pregnane X Receptor in Lipopolysaccharide/D-galactosamine-induced Acute Liver Injury
por: Wang, Kun, et al.
Publicado: (2009)

Protective Effects of Costunolide Against D-Galactosamine and Lipopolysaccharide-Induced Acute Liver Injury in Mice
por: Mao, Jingxin, et al.
Publicado: (2018)

Short‐term fasting attenuates lipopolysaccharide/D‐galactosamine‐induced acute liver failure through Sirt1‐autophagy signaling in mice
por: Long, Boyu, et al.
Publicado: (2023)

Rejuveinix Shows a Favorable Clinical Safety Profile in Human Subjects and Exhibits Potent Preclinical Protective Activity in the Lipopolysaccharide-Galactosamine Mouse Model of Acute Respiratory Distress Syndrome and Multi‐Organ Failure
por: Uckun, Fatih M., et al.
Publicado: (2020)

Fulminant hepatic failure (FHF) due to acute hepatitis C
por: Younis, Bilal Bin, et al.
Publicado: (2015)

Hepatoprotective activity of Lepidium sativum seeds against D-galactosamine/lipopolysaccharide induced hepatotoxicity in animal model
por: Raish, Mohammad, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_45mp6hrq84pgubvr8405e32uuf